Healthcare Market Research Reports
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Fludara Fludara and Campath/MabCampath, Treanda, |
Upcoming |
|
|
FCR Regimen FCR Regimen and Campath/MabCampath, Treanda, |
Upcoming |
|
|
FC Regimen FC Regimen and Campath/MabCampath, Treanda, |
Upcoming |
|
|
Bosutinib Bosutinib and Lab-on-chips (Microfluidics), |
Upcoming |
|
|
Gleevec Gleevec and Lab-on-chips (Microfluidics), Microreactors,... |
Upcoming |
|
|
Sprycel Sprycel and Lab-on-chips (Microfluidics), Microreactors,... |
Upcoming |
|
|
Phase II Phase II and Phase I and Phase III adds up to total Pipeline Drugs market. ... |
Upcoming |
|
|
Phase III Phase III and Phase I and Phase II adds up to total Pipeline Drugs market. ... |
Upcoming |
|
|
Phase I (NHL) Phase I (NHL) and Phase II (NHL) and Phase III (NHL) adds up to total... |
Upcoming |
|
|
Phase II (NHL) Phase II (NHL) and Phase I (NHL) and Phase III (NHL) adds up to total... |
Upcoming |
|
|
Phase III (NHL) Phase III (NHL) and Phase I (NHL) and Phase II (NHL) adds up to total... |
Upcoming |
|
|
Phase I (AML) Phase I (AML) and Phase II (AML) and Phase III (AML) adds up to total... |
Upcoming |
|
|
Phase II (AML) Phase II (AML) and Phase I (AML) and Phase III (AML) adds up to total... |
Upcoming |
|
|
Phase III (AML) Phase III (AML) and Phase I (AML) and Phase II (AML) adds up to total... |
Upcoming |
|
|
Phase I (B-cell Lymphoma) Phase I (B-cell Lymphoma) and Phase II (B-cell Lymphoma) and |
Upcoming |
|
|
Phase II (B-cell Lymphoma) Phase II (B-cell Lymphoma) and Phase I (B-cell Lymphoma) and |
Upcoming |
|
|
Phase III (B-cell Lymphoma) Phase III (B-cell Lymphoma) and Phase I (B-cell Lymphoma) and |
Upcoming |
|
|
Phase I (Pancreatic Cancer) Phase I (Pancreatic Cancer) and Phase II (Pancreatic Cancer) and |
Upcoming |
|
|
Phase II (Pancreatic Cancer) Phase II (Pancreatic Cancer) and Phase I (Pancreatic Cancer) and |
Upcoming |
|
|
Phase III (Pancreatic Cancer) Phase III (Pancreatic Cancer) and Phase I (Pancreatic Cancer) and |
Upcoming |
Healthcare
